Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
40.2M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
+2.98M
-
Total reported value, excl. options
-
$612M
-
Value change
-
+$70.4M
-
Number of buys
-
50
-
Number of sells
-
-5
-
Price
-
$23.50
Significant Holders of ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) as of Q3 2024
69 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value as of Q3 2024.
ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 40.2M outstanding shares and own 64.41% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4.48M shares), ORBIMED ADVISORS LLC (3.03M shares), FMR LLC (2.12M shares), Octagon Capital Advisors LP (1.98M shares), BlackRock, Inc. (1.93M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.85M shares), Sofinnova Investments, Inc. (1.7M shares), Novo Holdings A/S (1.51M shares), General Catalyst Group Management, LLC (1.49M shares), and VANGUARD GROUP INC (1.35M shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.